In the pursuit of first-in-class and best-in-class assets, our client’s strategic research team synthesizes scientific and commercial data across a vast range of therapeutic areas. This includes assessing the validity of novel drug targets, exploring unmet needs, and analyzing market dynamics. While their internal reports were rich in insights, they were stored in static documents and scattered across siloed systems - limiting discoverability and slowing decision-making. Teams spent hours logging into multiple databases - PubMed, clinicaltrials.gov, Citeline, GlobalData, Evaluate Pharma, and others - then manually stitching together findings to inform a single strategy question. As scientific innovation accelerates and data volume grows exponentially, the manual nature of this process became unsustainable. There was a clear need for a more intelligent, scalable, and unified way to surface insights and make confident decisions across clinical, commercial, and R&D stakeholders.

Vivo transformed this challenge by creating a centralized, conversational research portal that unifies and contextualizes the biopharma landscape. The platform integrates public sources like PubMed and clinicaltrials.gov with premium subscriptions - Citeline, GlobalData, Evaluate Pharma, KOL reports - and the client’s proprietary research, surfacing insights across scientific data, clinical trials, standards of care, unmet needs, and market forecasts. Users can now ask complex portfolio questions in plain language and receive clear, citation-backed answers, with the ability to view, summarize, and download source materials. Vivo enables intelligent source selection to align answers to different decision-making contexts, ensuring strategic relevance across roles. This shift from fragmented reports to dynamic, on-demand knowledge access has empowered teams to accelerate research, expand strategic visibility, and make smarter pipeline and investment decisions.